Why has the average time to first patient enrollment for studies using OneStudyTeam's Referral Partner Interface increased by 30% this quarter?

Introduction

The increase in average time to first patient enrollment for studies using OneStudyTeam's Referral Partner Interface by 30% this quarter is a significant issue that requires immediate attention. This metric is crucial for the success of clinical trials and directly impacts our clients' ability to conduct timely research. I'll approach this problem systematically, focusing on identifying the root cause, validating hypotheses, and developing both short-term and long-term solutions.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be seasonal factors at play. Have we seen similar patterns in previous years during this quarter?

Why it matters: Seasonal trends could explain the increase and inform our solution approach. Expected answer: No significant seasonal patterns observed in previous years. Impact on approach: If seasonal, we'd focus on adapting to cyclical changes; if not, we'd investigate other factors.

• Considering user segments, I'm curious about the distribution of this increase. Is the 30% increase uniform across all types of studies or concentrated in specific therapeutic areas?

Why it matters: Helps identify if the issue is systemic or specific to certain study types. Expected answer: The increase is more pronounced in oncology studies. Impact on approach: If concentrated, we'd focus on specific study types; if uniform, we'd look at platform-wide issues.

• Thinking about recent changes, have there been any significant updates to the Referral Partner Interface in the last quarter?

Why it matters: Recent changes could be directly related to the performance decline. Expected answer: A new feature for partner matching was implemented. Impact on approach: If recent changes exist, we'd scrutinize their impact; if not, we'd look at external factors or gradual system degradation.

• Regarding data integrity, has there been any change in how we measure or calculate the time to first patient enrollment?

Why it matters: Ensures we're comparing apples to apples and not facing a data anomaly. Expected answer: No changes in measurement methodology. Impact on approach: If changed, we'd need to recalibrate our analysis; if not, we can proceed with investigating actual performance issues.